Wikidata

(Q34442517)

English

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article

In more languages

Statements

title
Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
25297016
retrieved
2 August 2017
main subject
placebo
0 references
Alzheimer's disease
0 references
author name string
David Wilkinson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
25297016
retrieved
2 August 2017
Kristian Windfeld
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
25297016
retrieved
2 August 2017
Eskild Colding-Jørgensen
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
25297016
retrieved
2 August 2017
publication date
5 October 2014
1 reference
stated in
Europe PubMed Central
PubMed ID
25297016
retrieved
2 August 2017
page(s)
1092-1099
1 reference
stated in
Europe PubMed Central
PubMed ID
25297016
retrieved
2 August 2017
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34442517&oldid=1550963232"